Related Experiment Video
Updated: May 24, 2025

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
Published on: December 19, 2014
[A Case of Phaeohyphomycosis Caused by Exophiala xenobiotica in an Immunocompromised Host]
Reiko Saito1, Tomomichi Shimizu1, Akio Kondoh1
1Departments of Dermatology, Tokai University School of Medicine.
Abstract:
Phaeohyphomycosis is a rare subcutaneous fungal infection caused by melanin-containing brown-pigmented fungi. It typically occurs after skin injury in immunocompromised individuals. Herein, we report a case of phaeohyphomycosis caused by Exophiala xenobiotica in an immunocompromised elderly Japanese female. A subcutaneous mass on her left lower leg was totally removed but reappeared two months later. The subcutaneous mass resolved with additional seven months of 200 mg/day of oral itraconazole treatment. E. xenobiotica was identified as a new black yeast species in 2006. Genetic identification of the species was useful for identify the etiologic agent and choice of antifungal drugs.
Insights
Phaeohyphomycosis, a rare fungal infection, can affect immunocompromised individuals. This case highlights successful treatment of a recurring Exophiala xenobiotica infection with oral itraconazole.
Area of Science:
- Mycology
- Dermatology
- Infectious Diseases
Background:
- Phaeohyphomycosis is a rare subcutaneous fungal infection caused by pigmented fungi.
- It predominantly affects immunocompromised individuals following skin trauma.
- Exophiala xenobiotica is a black yeast species identified in 2006.
Purpose of the Study:
- To report a case of phaeohyphomycosis caused by Exophiala xenobiotica.
- To detail the clinical presentation, treatment, and outcome in an immunocompromised patient.
- To emphasize the role of species identification in guiding antifungal therapy.
Main Methods:
- Clinical case report of an immunocompromised elderly Japanese female.
- Surgical excision of a subcutaneous mass.
- Treatment with oral itraconazole.
- Identification of the causative agent, Exophiala xenobiotica.
Main Results:
- Recurrence of subcutaneous mass two months post-excision.
- Resolution of the mass after seven months of oral itraconazole (200 mg/day).
- Confirmation of Exophiala xenobiotica as the etiological agent.
Conclusions:
- Exophiala xenobiotica can cause recurrent subcutaneous phaeohyphomycosis in immunocompromised patients.
- Oral itraconazole is an effective treatment for this infection.
- Accurate fungal identification is crucial for selecting appropriate antifungal drugs.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

